We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.1%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
-$227M
(-4.4%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-2.42%
Top 10 Holdings %
Top 10 Hldgs %
24.91%
Holding
802
New
109
Increased
252
Reduced
267
Closed
54
Avg Time Held
1.6
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ventas
VTR
|
+$29.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$28.3M |
| 3 |
Ecolab
ECL
|
+$25.4M |
| 4 |
Merck
MRK
|
+$24.7M |
| 5 |
Edwards Lifesciences
EW
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ServiceNow
NOW
|
+$44M |
| 2 |
SBA Communications
SBAC
|
+$43.3M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$42M |
| 4 |
TD Ameritrade Holding Corp
AMTD
|
+$40.5M |
| 5 |
Gilead Sciences
GILD
|
+$39.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.75% |
| 2 | Consumer Discretionary | 15.42% |
| 3 | Technology | 15.27% |
| 4 | Financials | 12.99% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Ashford Hospitality Trust Series D
AHT.PRD
$4.18M
| $1.73M | 0.03% |
73,505
+1,010
| +1% | +$22.9K |
2013 Q3
10 quarters
|
|
202
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
| $1.72M | 0.03% |
32,093
+114
| +0.4% | +$6.69K |
2013 Q2
11 quarters
|
|
203
FedEx
FDX
$69.9B
| $1.7M | 0.03% |
10,437
+200
| +2% | +$27.8K |
2013 Q2
11 quarters
|
|
204
Walmart Inc
WMT
$935B
| $1.7M | 0.03% |
74,256
-501
| -0.7% | -$11K |
2013 Q2
11 quarters
|
|
205
United Airlines
UAL
$32.9B
| $1.68M | 0.03% |
28,136
-31,548
| -53% | -$1.68M |
2015 Q4
1 quarter
|
|
206
Medtronic
MDT
$122B
| $1.67M | 0.03% |
22,237
+593
| +3% | +$44.7K |
2013 Q2
11 quarters
|
|
207
MPLX
MPLX
$57.9B
| $1.65M | 0.03% |
55,625
+3,075
| +6% | +$83.4K |
2014 Q1
8 quarters
|
|
208
Grand Canyon Education
LOPE
$4.21B
| $1.65M | 0.03% |
38,482
-7,173
| -16% | -$276K |
2013 Q2
11 quarters
|
|
|
FULLL
209
DELISTED
Great Elm Capital Corp. 8.25% Notes due 2020
FULLL
| $1.63M | 0.03% |
64,600
+6,205
| +11% | +$155K |
2013 Q2
11 quarters
|
|
210
CBRE Group
CBRE
$39.2B
| $1.6M | 0.03% |
55,637
-578,255
| -91% | -$15.9M |
2014 Q2
7 quarters
|
|
211
iShares Preferred and Income Securities ETF
PFF
$12.1B
| $1.59M | 0.03% |
40,790
+25,318
| +164% | +$968K |
2013 Q2
11 quarters
|
|
212
Thermo Fisher Scientific
TMO
$258B
| $1.54M | 0.03% |
10,913
-20
| -0.2% | -$2.68K |
2015 Q2
3 quarters
|
|
|
MHNB.CL
213
DELISTED
Maiden Holdings North America
MHNB.CL
| $1.51M | 0.03% |
58,300
+13,200
| +29% | +$342K |
2013 Q2
11 quarters
|
|
214
LyondellBasell Industries
LYB
$20.2B
| $1.51M | 0.03% |
17,677
-154,248
| -90% | -$12.4M |
2013 Q2
11 quarters
|
|
215
T. Rowe Price
TROW
$21.6B
| $1.51M | 0.03% |
20,519
-134
| -0.6% | -$9.3K |
2013 Q2
11 quarters
|
|
216
Toyota
TM
$226B
| $1.5M | 0.03% |
14,087
-4,190
| -23% | -$463K |
2014 Q4
5 quarters
|
|
|
BWLD
217
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $1.49M | 0.03% |
10,075
-4,652
| -32% | -$711K |
2015 Q2
3 quarters
|
|
218
LKQ Corp
LKQ
$5.66B
| $1.49M | 0.03% |
46,526
+1,841
| +4% | +$51.3K |
2013 Q2
11 quarters
|
|
|
KIQ
219
DELISTED
Kelso Technologies Inc.
KIQ
| $1.48M | 0.03% |
1,679,809
+52,000
| +3% | +$46.9K |
2014 Q4
5 quarters
|
|
220
State Street Financial Select Sector SPDR ETF
XLF
$51.4B
| $1.47M | 0.03% |
74,479
-3,035
| -4% | -$57.8K |
2013 Q4
9 quarters
|
|
221
DELISTED
Praxair Inc
PX
| $1.45M | 0.03% |
12,651
+29
| +0.2% | +$3.03K |
2013 Q2
11 quarters
|
|
222
Invesco QQQ Trust
QQQ
$487B
| $1.44M | 0.03% |
13,201
-1,611
| -11% | -$167K |
2013 Q2
11 quarters
|
|
|
EXAM
223
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $1.43M | 0.03% |
48,450
-3,382
| -7% | -$91.9K |
2013 Q3
10 quarters
|
|
224
Super Micro Computer
SMCI
$23.1B
| $1.43M | 0.03% |
418,170
-201,170
| -32% | -$602K |
2014 Q4
5 quarters
|
|
225
Eli Lilly
LLY
$1.12T
| $1.4M | 0.03% |
19,485
-1,397
| -7% | -$106K |
2013 Q2
11 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Geneva Advisors held 802 positions worth $4.97B, down 4.4% from $5.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Geneva Advisors's Q1 2016 filing shows 109 new, 252 increased, 267 reduced and 54 closed positions. Its largest new stake was Ventas: 517,036 shares worth $32.6M. The largest sale was ServiceNow, an estimated $44M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
- Geneva Advisors's largest Q1 2016 buy was Ventas: 517,036 shares worth $32.6M.
- Geneva Advisors added most to Bristol-Myers Squibb in Q1 2016, an estimated $28.3M increase.
- Geneva Advisors's biggest Q1 2016 reduction was SBA Communications, cutting an estimated $43.3M.
- Geneva Advisors fully exited ServiceNow in Q1 2016, selling an estimated $44M.
- Geneva Advisors's ten largest holdings make up 25% of its $4.97B portfolio in Q1 2016.
- Geneva Advisors opened 109 new positions and closed 54 in Q1 2016.
- Geneva Advisors's portfolio value fell 4.4% quarter-over-quarter to $4.97B.
Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.